| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Epizyme, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 800,000 | $448,000 | $0.5600 | 01 Apr 2022 | Direct |
| Kaleido Biosciences, Inc. | COO & General Counsel | Stock Option (Right to Buy) | 100,000 | 01 Sep 2021 | Direct | ||
| Kaleido Biosciences, Inc. | COO & General Counsel | Restricted Stock Units | 4,517 | 28 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322028861-korn-jerald-2022-08-12 | Epizyme, Inc. | 12 Aug 2022 | 0 | $0 | 4 | Chief Operating Officer | 16 Aug 2022, 18:55 |
| /report/000089924322013466-korn-jerald-2022-04-01 | Epizyme, Inc. | 01 Apr 2022 | 1 | $0 | 4 | Chief Operating Officer | 04 Apr 2022, 18:48 |
| /report/000089924322011723-korn-jerald-2022-03-21 | Epizyme, Inc. | 21 Mar 2022 | 0 | $0 | 3 | Chief Operating Officer | 21 Mar 2022, 18:04 |
| /report/000120919122014673-korn-jerald-2022-02-28 | Kaleido Biosciences, Inc. | 28 Feb 2022 | 1 | -$3,049 | 4 | COO & General Counsel | 02 Mar 2022, 15:05 |
| /report/000120919122003530-korn-jerald-2022-01-14 | Kaleido Biosciences, Inc. | 14 Jan 2022 | 2 | $0 | 4 | COO & General Counsel | 18 Jan 2022, 16:12 |
| /report/000120919121054432-korn-jerald-2021-09-01 | Kaleido Biosciences, Inc. | 01 Sep 2021 | 1 | $0 | 4 | General Counsel | 02 Sep 2021, 16:20 |